Join
Live feed
·
INSIDERFilingvia Quantisnow
Rapport Therapeutics Inc. logo

Large owner Arch Venture Partners Xii, Llc converted options into 3,728,738 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RAPP· Rapport Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RAPP (Rapport Therapeutics Inc.) and more on Quantisnow.